VNVC and Sanofi Sign a Joint Statement to Produce Three Next-Generation Vaccines in Vietnam.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
VNVC and Sanofi (France) prioritize the production of 6-in-1, influenza, and meningococcal vaccines in Vietnam, expected to begin in 2028 and commercialize from 2029, aiming to supply tens of millions of doses annually. VNVC sponsors a support package of over 10 billion VND to protect the health of soldiers and civilians in Con Dao. VNVC signs an agreement to purchase a world-leading modern vaccine production line. VNVC enters into a strategic p…
(Dan Tri Newspaper) - Sanofi Group (France) and Vietnam Vaccine Company (VNVC) recently reported on the roadmap for producing three next-generation vaccines in Vietnam, the first in Southeast Asia, to General Secretary and President To Lam and French President Emmanuel Macron.
On September 10th, the Vietnam Vaccine Company (VNVC) and the Sanofi Pharmaceutical Group (France) exchanged a Joint Statement on cooperation in the production of three next-generation vaccines in Vietnam, and also reported on the progress of the cooperation to General Secretary and President To Lam and French President Emmanuel Macron.
On September 10th, within the framework of the Vietnam-France Business Forum, the French pharmaceutical group Sanofi and Vietnam Vaccine Company (VNVC) reported on the positive progress of their cooperation in producing the first next-generation vaccine in Southeast Asia; and simultaneously signed a joint statement identifying priorities for the production of three top-priority next-generation vaccines for children and adults.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
